Pharmac has made a funding U-turn and announced it will fund two brands of hormone replacement patches – Estradot and Estradiol TDP Mylan – from December.

The annual tender process is a key mechanism for Pharmac to manage pharmaceutical expenditure at a relatively low ...

The redirection of Pharmac remains positive and continues towards a more adaptable and patient-centred approach to funding medicines,” Seymour affirmed.

Pharmac has made a funding U-turn and announced it will fund two brands of hormone replacement patches – Estradot and Estradiol TDP Mylan – from December. People will be able to use either brand of ...

People who need oestrogen patches will have access to two brands free of charge from 1 December. Pharmac announced they had ...

Pharmac’s decision to fund both Estradiol TDP Mylan and Estradot hormone replacement (HRT) patches is an important outcome for rural women, says Rural Women New Zealand (RWNZ).

Associate Health Minister David Seymour says the oestradiol patch funding decision is an example of Pharmac's new patient-centric approach.From ...

Payal, a 27-year-old Mahim resident, experienced a heart attack, shocking her family due to her age and the protective ...

Transdermal estradiol patches — the same ones used to curb menopause symptoms in women — are an effective alternative to luteinizing hormone–releasing hormone agonists to lower PSA levels in ...

Transdermal estradiol patches show similar PSA response to LHRHa when combined with ARPIs in metastatic prostate cancer. The STAMPEDE trial indicates tE2 patches offer a favorable safety profile, ...

Danish researchers found that the associated risk for blood clots was highest for estrogen-containing products, particularly the vaginal ring and skin patch. The combined estrogen-progestin pill ...

In addition, they were randomly assigned to receive either LHRH drugs or a transdermal patch containing estradiol, a form of the female hormone estrogen. Transdermal estradiol, currently used for ...